Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and ...

Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead has been testing it as an injectable form ...

Afton Scientific specializes in the sterile filling of small-volume injectable drugs, primarily for clinical trials and small ...

The pharma company said it believes there’s plenty of room for multiple industry players in the obesity drug market.

More than the Q2 results, Mohit Khanna believes the more important aspect would-be management commentary regarding the ...

The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx face growing criticism over ...

As many as 50 new greenfield plants are in the pipeline to come up in the next two years under the Production-linked Incentive (PLI) scheme for pharma and medical devices manufacturing, a senior ...

Data indicates crime rates are down. Crain’s contributor Steve Hendershot talks with host Amy Guth about why it might not ...

Ascendis Pharma has submitted a supplemental biologics licence application (sBLA) to the US Food and Drug Administration (FDA ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced the ...

ONYDA XR was developed using Tris Pharma’s proprietary drug-delivery technology to enable a once-a-day extended-release profile, and with its liquid formulation, patients now have an option that ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...